Short Interest in Clearmind Medicine Inc. (NASDAQ:CMND) Declines By 59.8%

Clearmind Medicine Inc. (NASDAQ:CMNDGet Free Report) was the target of a large decrease in short interest in March. As of March 15th, there was short interest totalling 92,700 shares, a decrease of 59.8% from the February 29th total of 230,700 shares. Based on an average daily trading volume, of 1,590,000 shares, the short-interest ratio is presently 0.1 days. Approximately 3.2% of the shares of the stock are short sold.

Clearmind Medicine Price Performance

Shares of CMND traded down $0.02 during mid-day trading on Thursday, reaching $1.15. The company had a trading volume of 35,550 shares, compared to its average volume of 1,670,891. Clearmind Medicine has a twelve month low of $0.92 and a twelve month high of $50.10. The company has a current ratio of 1.96, a quick ratio of 1.96 and a debt-to-equity ratio of 0.01. The company’s 50-day moving average is $1.42 and its 200-day moving average is $3.13.

Clearmind Medicine (NASDAQ:CMNDGet Free Report) last issued its earnings results on Monday, March 18th. The company reported ($0.90) earnings per share (EPS) for the quarter.

Institutional Investors Weigh In On Clearmind Medicine

A number of large investors have recently bought and sold shares of CMND. Walleye Capital LLC acquired a new stake in shares of Clearmind Medicine in the 3rd quarter valued at about $62,000. Geode Capital Management LLC bought a new position in Clearmind Medicine in the 1st quarter worth approximately $59,000. Finally, Warberg Asset Management LLC purchased a new stake in Clearmind Medicine in the 3rd quarter worth approximately $35,000. 96.05% of the stock is currently owned by institutional investors.

About Clearmind Medicine

(Get Free Report)

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.

Further Reading

Receive News & Ratings for Clearmind Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearmind Medicine and related companies with MarketBeat.com's FREE daily email newsletter.